about
Cancer as a metabolic diseaseBioengineering Models for Breast Cancer ResearchCurrent State of Animal (Mouse) Modeling in Melanoma ResearchRebuilding cancer metastasis in the mouseMouse model of lymph node metastasis via afferent lymphatic vessels for development of imaging modalitiesMouse models in liver cancer research: A review of current literatureTumor-vascular interactions and tumor dormancyUltrasound mediated delivery of drugs and genes to solid tumors.Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.Chromosomal assignment of canine THADA gene to CFA 10q25.A medaka model of cancer allowing direct observation of transplanted tumor cells in vivo at a cellular-level resolution.β-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model.Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cellsBrain metastasis-initiating cells: survival of the fittest.Optimized mouse model for the imaging of tumor metastasis upon experimental therapy.A reconstructed metastasis model to recapitulate the metastatic spread in vitro.Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesisThe importance of being a lumen.Mouse models of breast cancer metastasis.Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic systemBioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation.Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceRac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.Platelet glycoprotein Ib alpha supports experimental lung metastasisConnections between epigenetic gene silencing and human disease.Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models.Butein inhibits metastatic behavior in mouse melanoma cells through VEGF expression and translation-dependent signaling pathway regulation.Osteosarcoma models: from cell lines to zebrafishIn vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression.Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAFMouse models of advanced spontaneous metastasis for experimental therapeutics.Preclinical approaches to study the biology and treatment of brain metastases.Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases.MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.A microphysiological system model of therapy for liver micrometastases
P2860
Q21245061-9BF8541A-EF1F-4193-8EF5-3F0413E58C3EQ26770495-B9FF5547-801C-434C-A0A3-2BE2EB04DBC3Q26781652-D57C30DA-192F-4B75-98FF-02CC9C1CF74CQ26864450-98DF69FC-DD6C-456E-8273-970D1FC51D73Q27316237-F8EA4A81-A83E-448F-94EA-A28292864782Q27490350-FD658FA9-DB1C-45CF-9EEE-A405F298DC7AQ28295975-C1673CBD-CD83-42D8-86A7-2C65609B81B2Q30488681-BAD74D5A-93A8-4750-88D5-B3071E9D5816Q33222808-EF86F9E6-17E3-4EF4-BDF4-A4AB3966C1FDQ33340126-636D5E94-E85F-44FE-8AE2-2F01395C8A04Q33492046-DD27BFE0-F41E-4635-89B5-9C9889258CD7Q33648101-7C5A5CDC-28B9-49C6-885E-514CB9CF6502Q33700061-41D01E8D-B28B-4086-BF58-C0994C3F751CQ33705623-087E41A8-4D8C-4B1E-8C13-9C32442B446CQ33755959-86135E6B-7897-40B7-86D7-620CB710A82AQ34071624-FB2D9709-445D-4ADA-87F8-B336B780B9E6Q34115770-1692A538-048E-4907-8B0F-8B3ABCB16499Q34145860-5F9CEB1F-AEE3-48DC-98E2-6FB4F0527402Q34356100-F3CD55A6-E96B-4896-AD3E-8B8B3D757DB8Q34553964-766108F4-DAA9-47A4-AC14-78105B95066CQ34626551-3511BBFD-6D3F-4DC2-963D-407C43AEE733Q34687026-01E64AE2-12AC-4F25-97AF-8FBF3CD847BDQ34713778-822BD526-03BD-4664-A71C-92C62A67CC35Q34778528-28D951B4-5B71-443C-825B-1B65B643E8DEQ34912116-0CD70E87-208E-4ABC-868D-80DF713AFB9BQ34990925-B8A53B23-6B1F-4C4C-8D8A-AA64D37A09D4Q35158209-0E8AAC51-7D26-4D15-8C69-206AB9B11C2AQ35661386-3B029705-FA26-4B8C-95F0-8F0C8F110F47Q35829198-30E51A36-9325-425F-BEA0-82AAB20568A7Q35843804-01D277E5-A56F-4786-8D59-DF2058B13968Q35870447-E2F0A133-790A-47FA-9A10-EDBDA41B66BCQ35875431-A6A95FC2-5B31-4391-A143-3D99AD2DF7BDQ35897787-D1342565-7F3D-4755-931A-4FEC08417743Q35904176-EBB96F3E-9C70-46C2-BACD-38DB2C467ADBQ35914464-54015F5C-BC0D-494C-8D10-20B2F91D6450Q35966786-8F8516D2-8199-4503-8E33-82562CC505D3Q35967411-3E2D82DF-75CA-417E-B58E-D0226433D31AQ36015382-46CF0FAA-859C-4CB4-8CFD-DB7055A3CA3EQ36018529-4B20491A-B099-4195-B3E0-27F4F6990FBCQ36072561-DF69370F-CA01-42DF-81CD-CCD8522B27BB
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Modeling metastasis in vivo.
@ast
Modeling metastasis in vivo.
@en
Modeling metastasis in vivo.
@nl
type
label
Modeling metastasis in vivo.
@ast
Modeling metastasis in vivo.
@en
Modeling metastasis in vivo.
@nl
prefLabel
Modeling metastasis in vivo.
@ast
Modeling metastasis in vivo.
@en
Modeling metastasis in vivo.
@nl
P356
P1433
P1476
Modeling metastasis in vivo.
@en
P2093
Chand Khanna
Kent Hunter
P304
P356
10.1093/CARCIN/BGH261
P407
P577
2004-09-09T00:00:00Z